Regression of a plasmablastic lymphoma in a patient with HIV on highly active antiretroviral therapy

Leukemia and Lymphoma

Volumn 43, Issue 2, 2002, Pages 423-426

  Nasta, Sunita D ^a   Carrum, George M ^b   Shahab, Imran ^b   Hanania, Nicola A ^b   Udden, Mark M ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

AIDS related lymphoma; Highly active anti retroviral therapy; Plasmablastic lymphoma

Indexed keywords

AMPRENAVIR; ANTIRETROVIRUS AGENT; BIOLOGICAL MARKER; CD79A ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; IMMUNOGLOBULIN HEAVY CHAIN; LYMPHOCYTE ANTIGEN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITONAVIR; STAVUDINE; SYNDECAN 1; UNCLASSIFIED DRUG; VINCRISTINE; VS38C ANTIGEN;

ABDOMINAL CANCER; ADULT; AIDS RELATED COMPLEX; ARTICLE; B LYMPHOCYTE; CANCER COMBINATION CHEMOTHERAPY; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CASE REPORT; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FOLLOW UP; GENE REARRANGEMENT; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEDIASTINUM MASS; NEEDLE BIOPSY; NONHODGKIN LYMPHOMA; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECTUM CANCER; T LYMPHOCYTE; TUMOR BIOPSY; TUMOR VOLUME;

ADULT; ANTI-HIV AGENTS; HIV INFECTIONS; HUMANS; LYMPHOMA, AIDS-RELATED; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; REMISSION INDUCTION;

EID: 0036192989     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190290006260     Document Type: Article

References (18)

1. "Combination antiretroviral therapy and incidence of AIDS-related malignancies"
2. "The epidemiology of acquired immunodeficiency syndrome malignancies"
3. "Acquired immunodeficiency syndrome-related lymphoma: Clinical aspects"
4. "Plasmablastic lymphomas of the oral cavity: A new entity associated with the human immunodeficiency virus infection"
5. "AIDS-related plasmablastic lymphomas of the oral cavity and jaws: A diagnostic dilemma"
6. "Plasmablastic lymphoma: A new subcategory of human immunodeficiency virus-related non-Hodgkin's lymphoma"
7. "Absence of immunohistochemical evidence for human herpesvirus 8(HHV8) in oral cavity plasmablastic lymphoma in an HIV-positive man"
8. "Oral plasmablastic lymphoma in previously undiagnosed HIV disease"
9. "Highly active antiretroviral therapy (HAART) and prolonged survival of a patient with an HIV-related Burkitt lymphoma, despite an intracardiac relapse"
10. "Effect of highly active antiretroviral therapy on the incidence of HIV-associated malignancies at an urban medical center"
11. "AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy"
12. "Highly Active Antiretroviral Therapy and Incidence of Cancer in Human Immunodeficiency Virus-Infected Adults"
13. "AIDS across Europe, 1994-1998: The EuroSIDA study"
14. "High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy"
15. "Highly active antiretroviral therapy (HAART) with high dose chemotherapy (HDC) and autologous stem cell transplantation (ASCT): Effects on HIV infection"
16. "Primary effusion lymphoma (PEL)-Complete remission with HAART (case report)"
17. "Is there a role for immunotherapy in controlling HIV infection"
18. "Immune restoration with antiretroviral therapies: Implications for clinical management"